Intended for UK Healthcare Professionals only. Adverse Event Reporting information can be found at the bottom of the page.
This website contains promotional information

Welcome to the MEDICE UK health family

All of us at MEDICE are passionate about bringing innovative healthcare solutions to patients, carers and clinicians across the UK. Our strong family roots have enabled us to be where we are today and we couldn’t be prouder of everything we have achieved. Our vision inspires every one of us, and our collective expertise drives us forward, as we continue to make our vision come alive.

Get to know us
A picture of a happy family of three

We are committed to supporting patients and clinicians across specialist therapy areas

At MEDICE, our innovative approach to medicine means we always look at the needs of clinicians and patients across therapy areas. This allows us to offer our unique expertise and develop meaningful solutions and treatments based on the latest evidence.

Our specialist treatments in the UK

Explore our range of treatments available to support appropriate patients and help them manage the impact of their condition

Attention deficit hyperactivity disorder (ADHD)

A photo of Medikinet® XL ▼ packaging

Medikinet® XL (methylphenidate hydrochloride)

Medikinet® XL is a prescription-only drug. For further information on this product, please see the package insert.

Learn more
A photo of Medikinet® tablets packaging

Medikinet® (methylphenidate hydrochloride) tablets

Medikinet® tablets adult is a prescription-only drug. For further information on this product, please see the package insert

Learn more
A photo of Amfexa® packaging

Amfexa® (dexamfetamine sulfate)

Amfexa® is a prescription-only drug. For further information on this product, please see the package insert.

Learn more

The latest with MEDICE UK

Get the latest information on our products, initiatives and events.

A photo of a laptop displaying the Medice UK home page

Medice UK initiated in the UK

Medice are pleased to announce the initiation of Medice UK, the newest subsidiary of the European organisation

Learn more
A photo of the Medice UK ADHD sales team

UK ADHD Sales team trained and ready

Medice UK now have a team of 9 UK account managers who will be responsible for supporting healthcare professionals

Learn more
A photo of Berlin

Medice UK at the 16th International ADHD Conference in Berlin

Over the weekend of the 13th and 14th May Medice UK attended the 16th International ADHD Conference in Berlin

Learn more
A photo of some of the Medice UK team at the 9th World Congress on ADHD in Amsterdam

9th World Congress on ADHD – Amsterdam

18-20th May 2023, another opportunity to engage with ADHD experts from around the world

Learn more
A happy looking female with her hand on someone's shoulder

Join the MEDICE health family

Will you become part of our story?

Explore our current job opportunities at MEDICE UK.

Careers

Contact us

If you would like to find out more about our treatments or therapy area expertise, please contact us

Medikinet® XL

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare Professionals are asked to report any suspected adverse reactions.

References
  1. Medikinet® XL, Summary of Product Characteristics.
  2. Medikinet® tablets, Summary of Product Characteristics.
  3. Amfexa®, Summary of Product Characteristics.
Adverse event reporting
Adverse events should be reported. Reporting forms and information can be found at the Yellow Card Scheme; https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store.
Adverse events should be reported to MEDICE UK at medicalinformation@medice.co.uk
Please retain the reported medication and packaging for further investigation by MEDICE UK.
Reporting side effects can provide more information on the safety of this medicine.